Erin Cole is a Senior Principal Scientist at Bristol Myers Squibb, with a focus on PET Radiochemistry in Research and Development since April 2014. Cole has led high-impact projects including PD-L1 Adnectin [F-18]BMS-986192 and various other therapeutic agents across cardiovascular, immuno-oncology, immunology, oncology, and neuroscience. Prior to this role, Cole held positions as Principal Scientist, Senior Research Investigator I, and Research Investigator II, after serving as a Postdoctoral Research Fellow at the University of Michigan Medical School under Professor Peter J. H. Cole earned a PhD in Organic Chemistry from the University of Notre Dame and a BS in Chemistry, along with Biochemistry, Cell, and Molecular Biology from Drake University.
This person is not in any offices